SCHEMBL4775136

SCHEMBL4775136

Cc1nc2cc(C(=O)Nc3ccc4c(c3)CCN(C3CCC3)CC4)ccc2n1OC(=O)C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 8/20 0.43
SLC2A1 P11166 1/20 0.40
TRPV1 Q8NER1 1/20 0.40
MAPT P10636 3/20 0.39
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
RXFP1 Q9HBX9 3/20 0.39
HPGD P15428 2/20 0.38
HSP90AA1 P07900 1/20 0.38
KMT2A Q03164 1/20 0.38
L3MBTL3 Q96JM7 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KDM4E B2RXH2 1/20 0.38
CASP3 P42574 1/20 0.38
SENP7 Q9BQF6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4769825 0.81 HRH3 (0.41) HRH3KMT2AHRH1
Trifluoroacetic Acid SCHEMBL4765332 0.78 KMT2A (0.46) HRH3SLC2A1TRPV1MAPTRXFP1
Trifluoroacetic Acid SCHEMBL4775692 0.78 RAB9A (0.52) HRH3SLC2A1MAPTALDH1A1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL4770823 0.77 SLC2A1 (0.47) HRH3SLC2A1TRPV1MAPTALDH1A1
SCHEMBL4770918 0.77 HRH3 (0.43) HRH3SLC2A1TRPV1MAPTALDH1A1
Trifluoroacetic Acid SCHEMBL4767186 0.76 MAPT (0.46) HRH3SLC2A1MAPTRAB9ARXFP1
SCHEMBL4774510 0.76 RAB9A (0.57) HRH3MAPTALDH1A1SMN1; SMN2NPC1
Trifluoroacetic Acid SCHEMBL4772603 0.76 SLC2A1 (0.50) HRH3SLC2A1TRPV1MAPTALDH1A1
SCHEMBL4770147 0.75 HRH3 (0.46) HRH3MAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL4772606 0.75 HRH3 (0.41) HRH3SLC2A1TRPV1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP claimed
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists GLAXO GROUP LIMITED (GB) 2007-03-15 US claimed
EP-1713778-B1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LTD (GB) 2008-01-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060566-A1 Benzazepine derivatives as histamine h3 antagonists HRH3, HRH4, HRH1 HRH3 1/4885SLC2A1 4665/4885TRPV1 125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.